智慧型胰岛素笔市场规模、份额、成长分析（按类型、按可用性、按产品、按连接类型、按适应症、按最终用户、按地区）- 产业预测 2025-2032

2023 年智慧胰岛素笔市场规模价值 45 亿美元，预计将从 2024 年的 49.6 亿美元成长到 2032 年的 108.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.3%。

由于对有效糖尿病管理解决方案的需求不断增加，智慧胰岛素笔市场正在经历强劲成长。这些创新设备透过提供及时的提醒和警报来增强糖尿病患者的胰岛素管理，确保剂量一致。与现有胰岛素笔的兼容性增加了它的吸引力和易用性。透过轻鬆监测漏服剂量并维护全面的糖尿病状况，这些笔对于管理第 1 型和第 2 型糖尿病都非常有价值。此外，还监测温度范围和有效期，以确保胰岛素的安全处理。然而，COVID-19 疫情带来了挑战，限制了获得基本糖尿病服务的机会，并导致糖尿病状况无法控制。总体而言，智慧胰岛素笔为糖尿病照护提供了一种方便有效的方法。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

智慧型胰岛素笔市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 第一代笔
• 第二代笔

智慧胰岛素笔市场规模（按可用性和复合年增长率） (2025-2032)

• 市场概览
• 预先填充
• 可重复使用的

智慧胰岛素笔市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 智慧胰岛素笔
• 传统笔适配器

智慧胰岛素笔市场规模（按连接类型和复合年增长率）（2025-2032）

• 市场概览
• Bluetooth
• USB

智慧胰岛素笔市场规模（按适应症和复合年增长率） (2025-2032)

• 市场概览
• 1型糖尿病
• 2型糖尿病

智慧胰岛素笔市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 门诊手术中心
• 家庭护理设置

智慧胰岛素笔市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（USA）
• Medtronic plc（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Ypsomed Holding AG（Switzerland）
• Companion Medical（USA）
• Digital Medics Pty Ltd（Australia）
• Biocorp（France）
• Emperra GmbH（USA）
• E-Health Technologies（Germany）
• Bigfoot Biomedical, Inc.（USA）
• Hoffmann-La Roche AG（Switzerland）
• Tandem Diabetes Care, Inc.（USA）
• Insulet Corporation（USA）
• Abbott Laboratories（USA）
• Terumo Corporation（Japan）
• Owen Mumford Ltd.（UK）
• SOOIL Development Co., Ltd.（South Korea）
• Pendiq GmbH（Germany）
• DarioHealth Corp.（Israel）

结论和建议

Smart Insulin Pens Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.96 billion in 2024 to USD 10.87 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The smart insulin pen market is experiencing robust growth driven by the increasing demand for effective diabetes management solutions. These innovative devices enhance insulin administration for diabetic patients by providing timely reminders and alerts, ensuring consistent dosing. Their compatibility with existing insulin pens adds to their appeal and ease of use. By facilitating the monitoring of missed doses and maintaining a comprehensive diabetes profile, these pens are invaluable for managing both type 1 and type 2 diabetes. Additionally, they ensure the safe handling of insulin by monitoring temperature ranges and expiration dates. However, the COVID-19 pandemic posed challenges, restricting access to necessary diabetic services and resulting in unmanaged diabetes profiles. Overall, smart insulin pens offer a convenient and efficient approach to diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Insulin Pens Market Segments Analysis

Global Smart Insulin Pens Market is segmented by Type, Usability, Product, Connectivity Type, Indication, End User and region. Based on Type, the market is segmented into First Generation Pens and Second Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on Product, the market is segmented into Smart Insulin Pen and Adaptors for Conventional Pen. Based on Connectivity Type, the market is segmented into Bluetooth and USB. Based on Indication, the market is segmented into Type 1diabetesand Type 2 Diabetes. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Insulin Pens Market

The surge in the diabetic population, driven by modern lifestyles and increased demands on the younger generation, has significantly accelerated the market for insulin products. Among these, smart insulin pens have gained considerable traction in recent years. As individuals grapple with the challenges of managing diabetes amidst hectic schedules, traditional methods of tracking glucose levels and insulin dosing become increasingly cumbersome. Smart technology offers a practical solution to these challenges, enhancing convenience and accuracy. Furthermore, the rising prevalence of needle stick injuries has further amplified the appeal of smart insulin pens, prompting manufacturers to ramp up production to capture growing demand and boost revenues in the upcoming years.

Restraints in the Smart Insulin Pens Market

The elevated price point of smart insulin pens could negatively impact their demand worldwide. In developing regions, particularly in Africa, inadequate healthcare systems and unfavorable reimbursement policies deter patients from pursuing necessary treatments and utilizing advanced devices like smart insulin pens. This financial barrier not only limits access to these innovative tools but also exacerbates existing health disparities, as individuals in these areas struggle to receive proper diabetes management solutions. Consequently, the high costs associated with these devices pose a significant challenge to their widespread adoption, particularly in underserved markets where the need for effective diabetes management is critical.

Market Trends of the Smart Insulin Pens Market

The smart insulin pens market is experiencing significant growth driven by advancements in healthcare technology and a rising global diabetic population. Innovative research and development initiatives are facilitating the creation of more sophisticated devices, enhancing patient engagement and management of diabetes. As market manufacturers introduce cutting-edge products that address the unique needs of insulin users, the landscape is evolving to offer greater convenience and accuracy in diabetes care. Moreover, the increasing adoption of digital health solutions and smart connectivity features in insulin pens are anticipated to present lucrative growth opportunities in the coming years, solidifying the market's trajectory.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Smart Insulin Pens Market Size by Type & CAGR (2025-2032)

• Market Overview
• First Generation Pens
• Second Generation Pens

Global Smart Insulin Pens Market Size by Usability & CAGR (2025-2032)

• Market Overview
• Prefilled
• Reusable

Global Smart Insulin Pens Market Size by Product & CAGR (2025-2032)

• Market Overview
• Smart Insulin Pen
• Adaptors for Conventional Pen

Global Smart Insulin Pens Market Size by Connectivity Type & CAGR (2025-2032)

• Market Overview
• Bluetooth
• USB

Global Smart Insulin Pens Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Smart Insulin Pens Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings

Global Smart Insulin Pens Market Size & CAGR (2025-2032)

• North America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Usability, Product, Connectivity Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Usability, Product, Connectivity Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Companion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digital Medics Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocorp (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• E-Health Technologies (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DarioHealth Corp. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations